MB2 Overview

  • Founded
  • 2014


  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

MB2 General Information


Developer of a portfolio of drug candidates to treat diabetes and related metabolic diseases.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 12406 Horesham Street
  • Carmel, IN 46032
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MB2 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 29-Oct-2015 00.00 Completed Generating Revenue
1. Early Stage VC 28-Apr-2015 00.00 00.00 Completed Generating Revenue
To view MB2’s complete valuation and funding history, request access »

MB2 Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioCrossroads Venture Capital Minority 000 0000 000000 0
To view MB2’s complete investors history, request access »